Concentrix Corporation (CNXC) Stock Price & Analysis

Concentrix Corporation (CNXC) closed at USD 34.25 on Thursday, October 22, 2026, up 13.77% on the day. The US market is currently closed; this is not a live price.

The prior close was USD 30.11; the Oct 22, 2026 session ranged USD 30.28–34.59 on volume of 1,662,098 shares. Market capitalization is $2.09B, with a 52-week range of USD 19.12–48.08 (NMS). Source: Nexqual, retrieved October 23, 2026 at 07:56 UTC.

Also available as compact Markdown for AI agents: nexqual.com/CNXC.md

Key facts (CNXC)

Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (CNXC)

USDFY2021FY2022FY2023FY2024FY2025TTM
Revenue$5.59B$6.32B$7.11B$9.62B$9.83B$9.97B
Gross profit$1.97B$2.26B$2.58B$3.45B$3.44B—
Operating income$572M$640M$661M$596M-$918M-$2.08B
Net income$406M$435M$314M$251M-$1.28B-$2.39B
EPS (diluted)$7.70$8.28$5.70$3.71-$20.36—
Free cash flow$365M$461M$497M$429M$572M$575M
Gross margin35.3%35.7%36.2%35.9%35.0%—
Operating margin10.2%10.1%9.3%6.2%-9.3%-20.9%
Net margin7.3%6.9%4.4%2.6%-13.0%-24.0%
Revenue growth+18.4%+13.2%+12.5%+35.2%+2.2%—
Cash + short-term investments$182M$145M$295M$241M$327M—
Total debt$802M$2.22B$4.94B$4.74B$4.64B—

Fiscal years end Nov. EPS is split-adjusted.

Valuation (price ÷ last four quarters, through Aug 31, 2026) (CNXC)

P/S 0.2x · EV/Sales 0.6x · P/FCF 3.6x · P/B 1.2x · FCF yield 27.47% · Earnings yield -114.23% · Dividend yield (paid, TTM) 4.42% · Buyback yield (TTM) 4.74% · Net debt $4.13B · EV $6.22B

P/E at fiscal year-ends: Nov 2024 11.6x, Nov 2023 16.2x.

Superinvestors (SEC 13F-HR, Q2 2026) (CNXC)

2 of 80 tracked investors hold CNXC. Each row is the investor's latest 13F; change is vs their prior-quarter share count.

InvestorFirm% of portfolioValueChange
Richard PzenaPzena Investment Management0.22%$76.5MAdded +16.0%
Tweedy Browne0.02%$301KReduced -1.4%

Insider sales (SEC Form 4, open-market, last ~7 months) (CNXC)

0 of 1 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.

Trade dateInsiderRoleSharesValue% of holdings sold10b5-1 planInsider type
2026-04-29Groupe Bruxelles Lambert6,000,000$134M68.4%NoToo little history (no open-market trades in 2023–2025)

% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).

Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.

Insider purchases (SEC Form 4, open-market, last ~7 months) (CNXC)

2 purchases, $91K. Private placements, offerings, dividend reinvestment and employee stock purchase plan buys are excluded.

Trade dateInsiderRoleSharesValueAvg priceInsider type
2026-07-08Caldwell Christopher APresident and CEO1,000$21K21.25Too little history (no open-market trades in 2023)
2026-04-09Valentine Andre SChief Financial Officer2,500$70K27.95Too little history (no open-market trades in 2023–2025)

Analysts (CNXC)

Consensus Buy (mean 2.20 on a 1–5 scale), 5 analysts; mean target USD 32.6 (low 29, high 45).

Rating changes, last 120 days:

DateFirmActionRatingPrice target
2026-09-30Canaccord GenuityMaintainedBuy$45
2026-06-30B of A SecuritiesTarget loweredNeutral$32 → $26
2026-06-30Canaccord GenuityTarget loweredBuy$55 → $45
2026-06-30Barrington ResearchTarget loweredOutperform$38 → $30
2026-06-30BairdTarget loweredOutperform$40 → $30

Total return (dividends reinvested) (CNXC)

1Y (from 2025-10-23)5Y (from 2021-10-18)
Total return-24.6%-79.5%
S&P 500 (SPY)+14.9%+80.3%
Per year-24.6%-27.1%
Volatility (annualized)72.0%48.4%
Max drawdown-54.6% (Oct 2025→Jul 2026)-88.1% (Mar 2022→Jul 2026)

CNXC revenue by region (fiscal year ended Nov 30, 2025)

LineRevenueShare of totalYoY
OTHERS$5.06B51.5%+6.2%
United States$1.59B16.2%-0.1%
Philippines$1.13B11.5%+6.8%
France$1.05B10.7%-5.3%
United Kingdom$356.5M3.6%-9.7%
Germany$334.3M3.4%-13.8%
Canada$302.1M3.1%-1.8%
Total revenue$9.83B100%—

As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).

CNXC suppliers, customers and competitors (named in its 10-K)

RelationshipCompanySentence in the filing
CustomerIBM (IBM)“•Selectively Pursue Strategic Acquisitions: We have made targeted acquisitions to increase our technology expertise, enter new verticals and geographies, and increase our scale, including our acquisitions of the IBM Customer Care Business, Convergys Corporation, PK, ServiceSource, Webhelp, and SAI Digital.”
CustomerConvergys“•Selectively Pursue Strategic Acquisitions: We have made targeted acquisitions to increase our technology expertise, enter new verticals and geographies, and increase our scale, including our acquisitions of the IBM Customer Care Business, Convergys Corporation, PK, ServiceSource, Webhelp, and SAI Digital.”
CompetitorAccenture (ACN)“Our major competitors include Accenture plc, Capgemini SE, Cognizant Technology Solutions Corporation, Endava UK Ltd., EPAM Systems, Inc., ExlService Holdings, Inc., Foundever Group, Genpact Limited, Globant S.A., HCL Technologies Limited, Infosys Limited, TaskUs Inc., Tata Consultancy Services, Teleperformance S.A., TELUS Digital, Thoughtworks Holding, Inc., and TTEC Holdings, Inc.”

Quoted from the company's 10-K filed Jan 28, 2026.

Companies that name CNXC in their SEC reports

Relationship to CNXCCompanyFilingSentence
supplierMatinas BioPharma Holdings, Inc. (MTNB)10-K Mar 31, 2026“International, Inc., a publicly-traded customer journey experience company (NASDAQ: SREV) that was acquired in 2022 by Concentrix Corporation,”
supplierTD SYNNEX CORP (SNX)10-K Jan 27, 2026“On December 1, 2020, the Company completed the previously announced separation of its customer experience services business (the "Separation"), in a tax-free transaction for federal income tax purposes, which was accomplished by the distribution of one hundred percent of the outstanding common stock of Concentrix Corporation ("Concentrix").”

CNXC company outlook (results filed Sep 29, 2026)

Analysts expect $2.44B for the current quarter, in line with the midpoint of the company's guidance ($2.44B).

Quoted word-for-word from the SEC 8-K results press release.

CNXC analyst estimates and revisions

PeriodEPS estimate90 days agoChangeRevenue estimateAnalysts
Current quarter (ends Nov 2026)$2.92$3.17-8.0%$2.44B4
Next quarter (ends Feb 2027)$2.81$2.85-1.3%$2.43B3
Current fiscal year (ends Nov 2026)$11.05$11.20-1.3%$9.94B5
Next fiscal year (ends Nov 2027)$11.52$11.89-3.1%$9.82B5

CNXC options: expected move

ExpirationDaysATM implied volatilityExpected move
Nov 20, 20262974.9%±17.3%
Dec 18, 20265771.0%±22.8%
Jan 15, 20278571.1%±27.7%
Apr 16, 202717676.5%±42.0%

30-day implied volatility 67.5% vs 78.4% realized over the last 30 trading days. Put/call ratio (volume) 0.38. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.

Key Statistics (as of October 23, 2026 at 07:56 UTC)

PriceUSD 34.25
Change▲ 13.77% (up)
Previous CloseUSD 30.11
OpenUSD 30.63
Day RangeUSD 30.28 – 34.59
52-Week RangeUSD 19.12 – 48.08
Volume1,662,098 shares
Market Cap$2.09B
ExchangeNMS

Technical Analysis (CNXC)

Nexqual's technical model rates CNXC "BUY" based on 5 bullish and 2 bearish signals across 127 daily candles, as of October 23, 2026 at 07:56 UTC.

Overall SignalBUY
RSI (14)67.82 (neutral)
vs SMA50Above (USD 27.67)
MACD0.84 (positive)

Analyst Ratings (CNXC)

Wall Street analysts rate CNXC "Buy" based on 5 analysts, with a mean price target of USD 32.6 (range USD 29–45), per Nexqual as of October 23, 2026 at 07:56 UTC.

Consensus RatingBuy
Analyst Count5
Mean TargetUSD 32.6
High TargetUSD 45
Low TargetUSD 29
Buy / Hold / Sell3 / 2 / 0

Earnings (CNXC)

Next Earnings Date2026-09-29
EPS EstimateUSD 2.92
Revenue Estimate$2.44B

Recent Earnings History

QuarterActual vs Estimate
2026-08-31USD 2.92 vs est 2.7 ▲ beat
2026-05-31USD 2.63 vs est 2.64 ▼ miss
2026-02-28USD 2.61 vs est 2.65 ▼ miss
2025-11-30USD 2.95 vs est 2.91 ▲ beat

Source: Nexqual, October 23, 2026 at 07:56 UTC.

Financials & Fundamentals (CNXC)

Total Revenue$9.97B
Revenue Growth (latest quarter, YoY)-1.20%
Gross Margin+34.79%
Operating Margin+7.18%
Profit Margin-23.98%
ROE-78.22%
Debt / Equity2.99
Current Ratio1.23
Total Cash$244.69M
Total Debt$5.28B
Free Cash Flow (last four quarters to Aug 2026, SEC 10-Q / 10-K)$575.01M (5.8% of revenue)

Source: Nexqual, October 23, 2026 at 07:56 UTC.

Financial Health Score (CNXC)

Nexqual rates Concentrix Corporation's overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 07:56 UTC.

GrowthMixed — Revenue +2.2% YoY (annual), slow
ProfitabilitySolid — Gross margin 35%, operating 7% (last 12 months)
Balance SheetWeak — $245M cash and investments vs $4.38B debt (Aug 2026, SEC)
Cash FlowSolid — FCF $575M (last 4 quarters to Aug 2026, SEC), 6% margin
EfficiencyCritical — ROE -78%, ROA 3.5%

Ownership (CNXC)

Insider Ownership+15.62%
Institutional Ownership+113.69%
Shares Outstanding61.11M
Float47.21M
Short % of Float+17.60%

Source: Nexqual, October 23, 2026 at 07:56 UTC.

Leadership (CNXC)

Concentrix Corporation is led by Christopher A. Caldwell, President, CEO & Director, per Nexqual as of October 23, 2026 at 07:56 UTC.

President, CEO & DirectorChristopher A. Caldwell
Executive VP & CFOAndre S. Valentine
Executive Vice President of LegalJane C. Fogarty
Executive Vice President of Global Sales & Account ManagementCraig Gibson
Executive Vice President of Customer SuccessCormac J. Twomey

Major Backers & Investors (CNXC)

Notable institutional backers of Concentrix Corporation include FMR, LLC, Pzena Investment Management LLC, AQR Capital Management, LLC, according to Nexqual as of October 23, 2026 at 07:56 UTC.

Active Investors

InvestorStake
FMR, LLC9.35%
Pzena Investment Management LLC5.59%
AQR Capital Management, LLC5.35%
Kopernik Global Investors, Llc5.2%
UBS Group AG5.18%
Groupe Bruxelles Lambert S.A.4.54%
FIL LTD3.99%

Index Funds (Passive)

FundStake
BlackRock10.93%
Vanguard Group4.67%
Dimensional Fund Advisors4.3%

Source: Nexqual, October 23, 2026 at 07:56 UTC.

From Concentrix Corporation's Latest SEC 10-K Filing (filed 2026-01-28)

Key Strengths & Strategy (as disclosed to the SEC)

Legal & Regulatory Risks (Item 1A, quoted)

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

SymbolNamePriceChange
PONYPony AI Inc.USD 5.02▼ 0.4%
CHRNChronoScale Holdings CorporatioUSD 15.46▼ 6.98%
DXCDXC Technology CompanyUSD 16.08▲ 4.42%
CSQRCsquare, Inc.USD 14.9▼ 11.83%
PENGPenguin Solutions, Inc.USD 51.91▼ 11.08%
KDKyndryl Holdings, Inc.USD 15.2▲ 5.92%

Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 07:56 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt